MedTrace Logo

Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.

NCT00407784 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2007-03-07

No results posted yet for this study

Summary

This study aims to evaluate the diagnostic value of the Aldosterone-Renin Ratio (ARR)as a screening test for primary aldosteronism among hypertensives. The test characteristics will be studied. Furthermore, the effect of eplerenone, a selective aldosterone-receptor antagonist will be studied.

Conditions

Interventions

DRUG

eplerenone

Sponsors & Collaborators

Principal Investigators

  • A.H. van den Meiracker, MD, PhD · Erasmus Medical Center

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2009-11-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00407784 on ClinicalTrials.gov